Insight
Senolytics: Can we treat age-related diseases with a single drug
In the second part of our two-part series on senolytics, we focus on the handful of clinical trials that are underway for senolytics
Register for free access to this exclusive healthcare learning resource
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Already a subscriber? Log in
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
11 mins